← back to search

Shingo Matsumoto

Kanazawa University · JP
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Genomics and Diagnostics, and Lung Cancer Diagnosis and Treatment.
h-index
57
citations
12,756
works
757
NIH funding
primary concept
Medicine
email

Recent publications

Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF
Journal of the American College of Cardiology 2025cited by 20position: firstdoi
Finerenone and Atrial Fibrillation in Heart Failure
JAMA Cardiology 2025cited by 15position: firstdoi
Amivantamab plus lazertinib versus osimertinib as first-line treatment in EGFR-mutated advanced non-small cell lung cancer: MARIPOSA Asian subset
Lung Cancer 2025cited by 5position: middledoi
Non-invasive visualisation of long-lasting brain metabolic alterations in murine pseudo-infection model using parahydrogen-polarised [1-<sup>13</sup>C] pyruvate MRI.
2025cited by 1position: contributordoi
Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
JAMA Cardiology 2024cited by 34position: middledoi
Beta-Blocker Use and Outcomes in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fraction
European Journal of Heart Failure 2024cited by 16position: firstdoi
Parahydrogen-Induced <sup>13</sup>C Hyperpolarizer Using a Flow Guide for Magnetic Field Cycling to Evoke <sup>1</sup>H-<sup>13</sup>C Spin Order Transfer Toward Metabolic MRI.
2024cited by 1position: contributordoi
Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population
Nature Communications 2023cited by 67position: middledoi
Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection Fraction
Journal of the American College of Cardiology 2023cited by 4position: firstdoi
Hyperpolarized <sup>13</sup>C Magnetic Resonance Imaging as a Tool for Imaging Tissue Redox State, Oxidative Stress, Inflammation, and Cellular Metabolism.
2022cited by 10position: contributordoi
Hyperpolarized <sup>13</sup> C Magnetic Resonance Imaging of Fumarate Metabolism by Parahydrogen-induced Polarization: A Proof-of-Concept in vivo Study.
2021cited by 21position: contributordoi
Hyperpolarized <sup>13</sup> C Magnetic Resonance Imaging of Fumarate Metabolism by Parahydrogen-induced Polarization: A Proof-of-Concept in vivo Study.
2021cited by 0position: contributordoi
Front Cover: Hyperpolarized <sup>13</sup>C Magnetic Resonance Imaging of Fumarate Metabolism by Parahydrogen‐induced Polarization: A Proof‐of‐Concept <i>in vivo</i> Study (ChemPhysChem 10/2021)
ChemPhysChem 2021cited by 0position: contributordoi
Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice.
2019cited by 25position: contributordoi
Macrophage derived TNFα promotes hepatic reprogramming to Warburg-like metabolism.
2019cited by 13position: contributordoi
Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc.
2019cited by 12position: contributordoi
Simultaneous T<sub>2</sub><sup>*</sup> mapping of <sup>14</sup>N- and <sup>15</sup>N-labeled dicarboxy-PROXYLs using CW-EPR-based single-point imaging.
2019cited by 7position: contributordoi
Synthesis and evaluation of &lt;sup&gt;13&lt;/sup&gt;C-labeled 5-5-dimethyl-1-pyrroline-N-oxide aimed at in vivo detection of reactive oxygen species using hyperpolarized &lt;sup&gt;13&lt;/sup&gt;C-MRI.
2019cited by 7position: contributordoi
Association between GWAS-identified lung adenocarcinoma susceptibility loci and<i>EGFR</i>mutations in never-smoking Asian women, and comparison with findings from Western populations
Human Molecular Genetics 2016cited by 67position: middledoi
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma
Nature Communications 2016cited by 58position: middledoi
Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302
Cancer & Metabolism 2015cited by 81position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 8 papers (2019–2025)Pardeep S. Jhund · Harvard University5 papers (2023–2025)John J.V. McMurray · University of Glasgow5 papers (2023–2025)Muthiah Vaduganathan · Harvard University4 papers (2024–2025)Brian Claggett · Harvard University3 papers (2024–2025)Alasdair D Henderson · University of London3 papers (2024–2025)Faı̈ez Zannad · Université de Caen Normandie3 papers (2023–2025)Bertram Pitt · Bayer (Germany)3 papers (2023–2025)Scott D. Solomon · Harvard University3 papers (2024–2025)Hiroshi Hirata · Hokkaido University of Science3 papers (2022–2025)Carolyn S.P. Lam · Duke-NUS Medical School3 papers (2024–2025) · 3 papers (2022–2025)Toru Yamaguchi · Transition State Technology Co. Ltd.3 papers (2021–2021)Sanjiv J. Shah · Akron General Medical Center2 papers (2024–2025)Johann Bauersachs · Duke University Hospital2 papers (2025–2025)James Lay‐Flurrie · Brigham and Women's Hospital2 papers (2024–2025) · 2 papers (2025–2025)Ross T. Campbell · Walter Reed Army Institute of Research2 papers (2023–2024)Toru Kondo · Nagoya University2 papers (2023–2024) · 2 papers (2024–2025)